DCF — ST VINCENT HEALTHCARE
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-465.9M
PV of Cash Flows
$-1.0B
PV of Terminal Value
$-1.7B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $566.3M | $-101.2M | -18.0% | $-125.2M | $-113.8M |
| Year 2 | $583.3M | $-98.4M | -17.0% | $-123.1M | $-101.8M |
| Year 3 | $600.8M | $-95.4M | -16.0% | $-120.8M | $-90.8M |
| Year 4 | $618.8M | $-95.2M | -15.0% | $-121.3M | $-82.9M |
| Year 5 | $637.4M | $-96.4M | -15.0% | $-123.4M | $-76.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$549.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1837625411720066
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5